5[1]Faloon BJ,Heagerty AM.In vitro perfusion study of human resistance artery function in essential hypertension.J Hypertens,1994,24:14
6[2]Ohtawa M,Takayama F,Saiton K.Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan,an orally active nonpeptide angiotension Ⅱ receptor antagonist,in human.Br J Clin Pharmacol,1993,25:290
7[3]Hegner G,Faust G,Freytag F,et al.A new antagonist for the treatment of essential hypertension:efficacy and safety compared to hydrochlorothiazide.Eur J Pharmacol,1997,52:173
8[4]Klaus D.The role of calcium antagonists in the treatment of hypertension.J Cardiovas Pharmacol,1998,20(suppl 6):s5
9[1]Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases[J]. Hypertens,1998, 31(part2):152-161
10[3]De Mello WC, Jan Danser AH. Angiotensin Ⅱ and the heart. On the intracrine renin-angiotensin system[J]. Hypertens,2000,35:1183-1188
